Aug 13, 2020
Biocept Announces Agreement with Healthcare Group to Provide COVID-19 Testing to Multi-State Locations
Aug 12, 2020
Biocept Reports Second Quarter 2020 Financial Results
Jun 22, 2020
Biocept Announces the Availability of 10,000 Specimen Collection Kits for RT-PCR COVID-19 Testing
May 29, 2020
Data Affirming Biocept's Target Selector(TM) Platform Identifies Cancer Mutations in Cerebrospinal Fluid Presented at ASCO 2020 Virtual Scientific Program
May 14, 2020
Biocept Expands its Menu of Molecular Assay Kit Offering with Release of its Target Selector(TM) BRAF Kit for Clients' Use in Their Own Laboratories
Apr 28, 2020
Biocept Announces CE-IVD Mark and Availability of its Target Selector(TM) EGFR Molecular Assay Kit in Europe
Apr 20, 2020
Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target Selector(TM) Technology Validated for Use in Both Tissue and Blood Samples
Apr 09, 2020
Brazil Patent Granted for Biocept's Target Selector(TM) Oncogene Mutation Enrichment and Detection Platform
Mar 26, 2020
Biocept Enters into Laboratory Services Agreement with Second California-Based Independent Physician Association
Mar 18, 2020
Biocept to Release 2019 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 25, 2020
Feb 14, 2020
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
Feb 10, 2020
Biocept Enters into Laboratory Services Agreement with California-Based Independent Physician Association
Jan 14, 2020
Biocept Announces Validation and Availability of its Liquid Biopsy Platform for the Detection of Actionable Cancer Biomarkers in Cerebrospinal Fluid
Dec 12, 2019
Biocept Announces Closing of $10.0 Million Underwritten Public Offering
Dec 09, 2019
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
Nov 13, 2019
Biocept Reports Third Quarter 2019 Financial Results
Nov 06, 2019
Biocept to Release Third Quarter 2019 Financial Results and Host Investor Conference Call on November 13, 2019
Oct 03, 2019
Biocept Announces Issuance of South Korean Patent Covering its Target Selector(TM) Oncogene Mutation Enrichment and Detection Platform
Sep 03, 2019
Biocept to Present at Two Investment Conferences in September
Aug 22, 2019
High Sensitivity of Biocept's Target Selector(TM) Platform Using CEE-Sure(TM) Blood Collection Tubes to Be Featured in Poster Presentation at the 2019 IASLC World Conference on Lung Cancer